Pg. 81 "There are three different forms of digestible carbohydrate: 1) monosaccharides (one sugar molecule--glucose or fructose or galactose; high-fructose corn syrup is an example of two monosaccharides at once); 2) disaccharides (two sugar molecules bound together; maltose (e.g., beer) is glucose-glucose, sucrose (e.g., fruit) is glucose-fructose, and lactose (e.g., milk) is glucose-galactose); and 3) starch, which is a string of glucose molecules polymerized together."
Pg. 90 "The end of the nineteenth century saw the creation of two alternative branches to challenge traditional medicine--osteopathy, which believed in a holistic approach to the patient; and chiropractic, which believed that many diseases came from disorders of the spine."
Pg. 94 "If osteopathy was flawed and dangerous to patients, why are osteopathic schools still thriving? From 2010 to 2016, the number of actively licensed DOs in the US increased by nearly 40 percent, from over fifty-eight thousand to over eighty-one thousand. I can state from experience that DO students are as research-focused as their MD student brethren--the big difference is that DO students are devoted to studying the whole patient, not just the diseased organ. Oh, and they get 'Food as Medicine.'"
Pg. 95 "Every single drug company spends more on marketing than on research and development. Some, like Johnson & Johnson, spend double their R&D budget on marketing."
Pg. 97 "The third most common cause of death today is prescription medication."
Pg. 98 "Currently, 70 percent of the US population is taking at least one prescribed medication. Is that because 70 percent of the population is sick? Well, actually yes. In fact, 88 percent of the population is thought to be metabolically ill. But does that mean the medicine is the treatment?"
Pg. 100 "Big Pharma needs doctors to power the machine that generates their profit. Only one-third ($26 billion) of their annual $85 billion profit comes from over-the-counter drugs that patients can buy without a prescription--and so Pharma has to keep doctors prescribing. The best way to do that? Control the medical school curriculum. And how to do that? Pay for stuff."
Pg. 101 "A 2017 U.S. Supreme Court case, Sorrell v IMS Health Inc., argues that Big Pharma can data mine information from patients, leaving open the possibility that drug companies can access patient records."
Pg. 90 "The end of the nineteenth century saw the creation of two alternative branches to challenge traditional medicine--osteopathy, which believed in a holistic approach to the patient; and chiropractic, which believed that many diseases came from disorders of the spine."
Pg. 94 "If osteopathy was flawed and dangerous to patients, why are osteopathic schools still thriving? From 2010 to 2016, the number of actively licensed DOs in the US increased by nearly 40 percent, from over fifty-eight thousand to over eighty-one thousand. I can state from experience that DO students are as research-focused as their MD student brethren--the big difference is that DO students are devoted to studying the whole patient, not just the diseased organ. Oh, and they get 'Food as Medicine.'"
Pg. 95 "Every single drug company spends more on marketing than on research and development. Some, like Johnson & Johnson, spend double their R&D budget on marketing."
Pg. 97 "The third most common cause of death today is prescription medication."
Pg. 98 "Currently, 70 percent of the US population is taking at least one prescribed medication. Is that because 70 percent of the population is sick? Well, actually yes. In fact, 88 percent of the population is thought to be metabolically ill. But does that mean the medicine is the treatment?"
Pg. 100 "Big Pharma needs doctors to power the machine that generates their profit. Only one-third ($26 billion) of their annual $85 billion profit comes from over-the-counter drugs that patients can buy without a prescription--and so Pharma has to keep doctors prescribing. The best way to do that? Control the medical school curriculum. And how to do that? Pay for stuff."
Pg. 101 "A 2017 U.S. Supreme Court case, Sorrell v IMS Health Inc., argues that Big Pharma can data mine information from patients, leaving open the possibility that drug companies can access patient records."